Wednesday, May 12, 2021 6:16:35 AM
Yaron Cherny joined Pluristem in 2021 and serves as VP Business Development. Mr. Cherny is a business development professional with over 15 years of experience in the life science field, specializing in identifying new opportunities. Before joining Pluristem, Mr. Cherny headed ShizimXL – ICB, an Israeli Chinese Innovation Center investing in Israeli medical device companies. Previous positions also include heading the Pharma Business Development of Teva Israel, the Israeli subsidiary of Teva Pharmaceutical Ltd., specializing in in-licensing of innovative products, and leading the Business Development of Kamada Ltd., in which he was responsible for Kamada’s out-licensing deals with multinational pharmaceutical companies. Mr. Cherny holds an LLM and BA in Finance from IDC Herzliya in Israel.
https://www.pluristem.com/the-company/
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM